Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Cactus
WHD
$5.2B
| $6.83M | ﹤0.01% |
330,973
+20,307
| +7% | +$352K |
|
|
NTUS
1877
DELISTED
Natus Medical Inc
NTUS
| $6.83M | ﹤0.01% |
312,797
-54,896
| -15% | -$1.26M |
|
1878
Unisys
UIS
$223M
| $6.81M | ﹤0.01% |
623,949
-62,504
| -9% | -$723K |
|
1879
Buckle
BKE
$2.33B
| $6.8M | ﹤0.01% |
433,652
-183,434
| -30% | -$2.75M |
|
|
CSW
1880
CSW Industrials
CSW
$5.5B
| $6.79M | ﹤0.01% |
98,170
+4,478
| +5% | +$302K |
|
|
ARCH
1881
DELISTED
Arch Resources, Inc.
ARCH
| $6.77M | ﹤0.01% |
238,370
+21,682
| +10% | +$674K |
|
|
AAMI
1882
Acadian Asset Management
AAMI
$3.19B
| $6.77M | ﹤0.01% |
543,448
+51,953
| +11% | +$425K |
|
1883
ATN International
ATNI
$372M
| $6.77M | ﹤0.01% |
111,785
-18,872
| -14% | -$1.13M |
|
|
PDLI
1884
DELISTED
PDL BioPharma, Inc.
PDLI
| $6.76M | ﹤0.01% |
2,322,843
-604,578
| -21% | -$1.91M |
|
1885
GameStop
GME
$8.61B
| $6.73M | ﹤0.01% |
6,198,980
-606,116
| -9% | -$700K |
|
1886
Unitil
UTL
$980M
| $6.72M | ﹤0.01% |
149,990
-47,916
| -24% | -$2.34M |
|
1887
Matthews International
MATW
$884M
| $6.72M | ﹤0.01% |
351,616
-2,607
| -0.7% | -$55.6K |
|
|
BBBY
1888
Bed Bath & Beyond
BBBY
$499M
| $6.71M | ﹤0.01% |
259,751
+11,165
| +4% | +$164K |
|
1889
Invesco Mortgage Capital
IVR
$764M
| $6.71M | ﹤0.01% |
179,358
+39,998
| +29% | +$1.38M |
|
|
ALX
1890
Alexander's
ALX
$1.37B
| $6.7M | ﹤0.01% |
27,789
+1,618
| +6% | +$434K |
|
|
VIVO
1891
DELISTED
Meridian Bioscience Inc
VIVO
| $6.67M | ﹤0.01% |
286,392
+16,133
| +6% | +$234K |
|
|
AEGN
1892
DELISTED
Aegion Corp
AEGN
| $6.64M | ﹤0.01% |
418,349
-40,717
| -9% | -$606K |
|
1893
Alector
ALEC
$164M
| $6.61M | ﹤0.01% |
270,504
+42,594
| +19% | +$1.18M |
|
|
WUBA
1894
DELISTED
58.com Inc
WUBA
| $6.6M | ﹤0.01% |
122,372
+5,566
| +5% | +$287K |
|
1895
Theravance Biopharma
TBPH
$874M
| $6.6M | ﹤0.01% |
314,210
+14,634
| +5% | +$376K |
|
|
KNL
1896
DELISTED
Knoll, Inc.
KNL
| $6.58M | ﹤0.01% |
539,359
-85,932
| -14% | -$946K |
|
1897
Dine Brands
DIN
$462M
| $6.55M | ﹤0.01% |
155,469
+542
| +0.3% | +$21.9K |
|
|
CCXI
1898
DELISTED
ChemoCentryx, Inc.
CCXI
| $6.54M | ﹤0.01% |
113,695
+10,612
| +10% | +$578K |
|
1899
National Healthcare
NHC
$3.5B
| $6.54M | ﹤0.01% |
103,065
-43,069
| -29% | -$2.89M |
|
1900
OFG Bancorp
OFG
$2.23B
| $6.49M | ﹤0.01% |
485,152
-290,159
| -37% | -$3.5M |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.